Literature DB >> 9426459

Expression, purification, and characterization of a soluble form of human cytomegalovirus glycoprotein B.

C Carlson1, W J Britt, T Compton.   

Abstract

The human cytomegalovirus glycoprotein B gene (gB; gpUL55) was truncated at amino acid 692 and recombined into Autographa californica nuclear polyhedrosis virus (baculovirus). Infection of insect cells with the recombinant baculovirus resulted in high-level expression and secretion of the truncated gB protein (gB-S) into the culture medium. Purification of gB-S by monoclonal antibody affinity chromatography yielded a protein of ca. 200 kDa. Characterization of the 200-kDa purification product indicated that the recombinant gB protein retained many structural and functional features of the viral gB. Comparison of electrophoretic migration patterns in reduced versus nonreduced protein samples and immune blotting analysis with antibodies specific for the amino or carboxy-terminus of gB demonstrated that the recombinant protein was composed of disulfide linked 69 kDa amino terminal and 35-kDa carboxy-terminal fragments. In addition, recognition of the 200-kDa gB-S by a conformational-dependent, oligomer-specific monoclonal antibody suggested that gB-S was properly folded and dimeric. Like the viral gB, gB-S had heparin binding ability. One heparin binding site was found to reside within the 35-kDa carboxy-terminal fragment (aa 492-692). Heparin binding was abolished when gB-S was denatured. These data suggest that gB contains a novel heparin binding motif that is at least partially conformational dependent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9426459     DOI: 10.1006/viro.1997.8892

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

1.  Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins.

Authors:  Elizabeth A Reap; Sergey A Dryga; John Morris; Bryan Rivers; Pamela K Norberg; Robert A Olmsted; Jeffrey D Chulay
Journal:  Clin Vaccine Immunol       Date:  2007-04-18

2.  The Human Cytomegalovirus Trimer and Pentamer Promote Sequential Steps in Entry into Epithelial and Endothelial Cells at Cell Surfaces and Endosomes.

Authors:  Jing Liu; Ted S Jardetzky; Andrea L Chin; David C Johnson; Adam L Vanarsdall
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

Review 3.  Human cytomegalovirus entry into cells.

Authors:  Adam L Vanarsdall; David C Johnson
Journal:  Curr Opin Virol       Date:  2012-01-30       Impact factor: 7.090

4.  Characterization of a panel of insertion mutants in human cytomegalovirus glycoprotein B.

Authors:  J Singh; T Compton
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies.

Authors:  Anna Kabanova; Laurent Perez; Daniele Lilleri; Jessica Marcandalli; Gloria Agatic; Simone Becattini; Silvia Preite; Dario Fuschillo; Elena Percivalle; Federica Sallusto; Giuseppe Gerna; Davide Corti; Antonio Lanzavecchia
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

6.  Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B.

Authors:  K A Boyle; T Compton
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

7.  Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B.

Authors:  Karl W Boehme; Jasbir Singh; Stuart T Perry; Teresa Compton
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Specific inhibition of human cytomegalovirus glycoprotein B-mediated fusion by a novel thiourea small molecule.

Authors:  Thomas R Jones; Shi-Wu Lee; Stephen V Johann; Vladimir Razinkov; Robert J Visalli; Boris Feld; Jonathan D Bloom; John O'Connell
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway.

Authors:  K A Boyle; R L Pietropaolo; T Compton
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

10.  Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo.

Authors:  Daniele Lilleri; Anna Kabanova; Antonio Lanzavecchia; Giuseppe Gerna
Journal:  J Clin Immunol       Date:  2012-07-27       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.